Antiretroviral Drugs and Risk of Chronic Alanine Aminotransferase Elevation in Human Immunodeficiency Virus (HIV)-Monoinfected Persons: The Data Collection on Adverse Events of Anti-HIV Drugs Study (Q31050092)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Antiretroviral Drugs and Risk of Chronic Alanine Aminotransferase Elevation in Human Immunodeficiency Virus (HIV)-Monoinfected Persons: The Data Collection on Adverse Events of Anti-HIV Drugs Study	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

15 August 2017

Antiretroviral Drugs and Risk of Chronic Alanine Aminotransferase Elevation in Human Immunodeficiency Virus (HIV)-Monoinfected Persons: The Data Collection on Adverse Events of Anti-HIV Drugs Study (English)

1 reference

Europe PubMed Central

15 August 2017

anti-retroviral agent

0 references

1 reference

based on heuristic

inferred from title

data collection

1 reference

based on heuristic

inferred from title

Antonella d'Arminio Monforte

9

object named as

Antonella d'Arminio Monforte

1 reference

Europe PubMed Central

15 August 2017

4

object named as

Lene Ryom

1 reference

Europe PubMed Central

15 August 2017

object named as

Caroline A Sabin

2

0 references

13

object named as

Jens D Lundgren

1 reference

Europe PubMed Central

15 August 2017

François Dabis

8

object named as

Francois Dabis

1 reference

Europe PubMed Central

15 August 2017

6

object named as

Matthew Law

1 reference

Europe PubMed Central

15 August 2017

Bruno Ledergerber

3

object named as

Bruno Ledergerber

1 reference

Europe PubMed Central

15 August 2017

Stéphane De Wit

11

object named as

Stephane de Wit

1 reference

Europe PubMed Central

15 August 2017

12

object named as

Ole Kirk

1 reference

Europe PubMed Central

15 August 2017

5

object named as

Peter Reiss

1 reference

Europe PubMed Central

15 August 2017

1

object named as

Helen Kovari

1 reference

Europe PubMed Central

15 August 2017

10

object named as

Colette Smith

1 reference

Europe PubMed Central

15 August 2017

author name string

Christian Pradier

7

1 reference

Europe PubMed Central

15 August 2017

Rainer Weber

14

1 reference

Europe PubMed Central

15 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

21 January 2016

1 reference

Europe PubMed Central

15 August 2017

Open Forum Infectious Diseases

1 reference

Europe PubMed Central

15 August 2017

3

1 reference

Europe PubMed Central

15 August 2017

1

1 reference

Europe PubMed Central

15 August 2017

ofw009

1 reference

Europe PubMed Central

15 August 2017

copyright license

Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International

11 November 2016

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Use of antiretroviral therapy and risk of end-stage liver disease and hepatocellular carcinoma in HIV-positive persons

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4767274

21 June 2018

Risk of Liver Enzyme Elevation During Treatment With Ritonavir-Boosted Protease Inhibitors Among HIV-Monoinfected and HIV/HCV-Coinfected Patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4767274

21 June 2018

Nonalcoholic Steatohepatitis and Hepatic Fibrosis in HIV-1-Monoinfected Adults With Elevated Aminotransferase Levels on Antiretroviral Therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4767274

21 June 2018

Liver transplantation for acute liver failure due to efavirenz hepatotoxicity: the importance of routine monitoring.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4767274

21 June 2018

EFV/FTC/TDF-associated hepatotoxicity: a case report and review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4767274

21 June 2018

Antiretroviral drug-related liver mortality among HIV-positive persons in the absence of hepatitis B or C virus coinfection: the data collection on adverse events of anti-HIV drugs study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4767274

21 June 2018

Abacavir/lamivudine versus tenofovir DF/emtricitabine as part of combination regimens for initial treatment of HIV: final results

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4767274

21 June 2018

The Coding Causes of Death in HIV (CoDe) Project: initial results and evaluation of methodology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4767274

21 June 2018

Influence of antiretroviral therapy on liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4767274

21 June 2018

Clinical syndromes and consequences of antiretroviral-related hepatotoxicity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4767274

21 June 2018

Prevalence and factors associated with liver test abnormalities among human immunodeficiency virus-infected persons

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4767274

21 June 2018

Hyperbilirubinemia during atazanavir treatment in 2,404 patients in the Italian atazanavir expanded access program and MASTER Cohorts.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4767274

21 June 2018

Nonalcoholic fatty liver disease among HIV-infected persons

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4767274

21 June 2018

Elevated serum alanine aminotransferase and gamma-glutamyltransferase and mortality in the United States population

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4767274

21 June 2018

Serum aminotransferase activity and mortality risk in a United States community.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4767274

21 June 2018

HCV/ HIV co-infection: time to re-evaluate the role of HIV in the liver?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4767274

21 June 2018

The prevalence and risk factors for abnormal liver enzymes in HIV-positive patients without hepatitis B or C coinfections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4767274

21 June 2018

Liver toxicity induced by non-nucleoside reverse transcriptase inhibitors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4767274

21 June 2018

Hepatic steatosis is associated with fibrosis, nucleoside analogue use, and hepatitis C virus genotype 3 infection in HIV-seropositive patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4767274

21 June 2018

Hepatic steatosis and antiretroviral drug use among adults coinfected with HIV and hepatitis C virus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4767274

21 June 2018

Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4767274

21 June 2018

Interactions between atazanavir-ritonavir and tenofovir in heavily pretreated human immunodeficiency virus-infected patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4767274

21 June 2018

Assessment of mitochondrial toxicity in human cells treated with tenofovir: comparison with other nucleoside reverse transcriptase inhibitors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4767274

21 June 2018

Phase i/ii trial of the pharmacokinetics, safety, and antiretroviral activity of tenofovir disoproxil fumarate in human immunodeficiency virus-infected adults

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4767274

21 June 2018

Incidence and risk factors for chronic elevation of alanine aminotransferase levels in HIV-infected persons without hepatitis b or c virus co-infection

1 reference

https://api.crossref.org/works/10.1093%2FOFID%2FOFW009

21 January 2018

Biomarkers to monitor safety in people on art and risk of mortality

1 reference

https://api.crossref.org/works/10.1093%2FOFID%2FOFW009

21 January 2018

Risk factors for advanced liver fibrosis in HIV-infected individuals: role of antiretroviral drugs and insulin resistance

1 reference

https://api.crossref.org/works/10.1093%2FOFID%2FOFW009

21 January 2018

Prevalence and risk factors for abnormal liver stiffness in HIV-infected patients without viral hepatitis coinfection: role of didanosine.

1 reference

https://api.crossref.org/works/10.1093%2FOFID%2FOFW009

21 January 2018

Association of noncirrhotic portal hypertension in HIV-infected persons and antiretroviral therapy with didanosine: a nested case-control study.

1 reference

https://api.crossref.org/works/10.1093%2FOFID%2FOFW009

21 January 2018

Liver damage underlying unexplained transaminase elevation in human immunodeficiency virus-1 mono-infected patients on antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1093%2FOFID%2FOFW009

21 January 2018

Combination antiretroviral therapy and the risk of myocardial infarction

1 reference

https://api.crossref.org/works/10.1093%2FOFID%2FOFW009

21 January 2018

Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection

1 reference

https://api.crossref.org/works/10.1093%2FOFID%2FOFW009

21 January 2018

A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1093%2FOFID%2FOFW009

21 January 2018

Does tenofovir increase efavirenz hepatotoxicity?

1 reference

https://api.crossref.org/works/10.1093%2FOFID%2FOFW009

21 January 2018

Combination therapy efavirenz/emtricitabine/tenofovir disoproxil fumarate associated with hepatic failure

1 reference

https://api.crossref.org/works/10.1093%2FOFID%2FOFW009

21 January 2018

Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial

1 reference

https://api.crossref.org/works/10.1093%2FOFID%2FOFW009

21 January 2018

Simplification of antiretroviral therapy with tenofovir-emtricitabine or abacavir-Lamivudine: a randomized, 96-week trial

1 reference

https://api.crossref.org/works/10.1093%2FOFID%2FOFW009

21 January 2018

Effect of tenofovir, an antiretroviral drug, on hepatic and renal functional indices of Wistar rats: protective role of vitamin E.

1 reference

https://api.crossref.org/works/10.1093%2FOFID%2FOFW009

21 January 2018

Drug-drug and drug-food interactions between tenofovir disoproxil fumarate and didanosine

1 reference

https://api.crossref.org/works/10.1093%2FOFID%2FOFW009

21 January 2018

Association Between ALT Level and the Rate of Cardio/Cerebrovascular Events in HIV-Positive Individuals

1 reference

https://api.crossref.org/works/10.1093%2FOFID%2FOFW009

21 January 2018

Does tenofovir influence efavirenz pharmacokinetics?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4767274

25 November 2018

The use of atazanavir in HIV-infected patients with liver cirrhosis: lack of hepatotoxicity and no significant changes in bilirubin values or model for end-stage liver disease score

1 reference

https://pubmed.ncbi.nlm.nih.gov/26925429

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1093/OFID/OFW009

1 reference

Europe PubMed Central

15 August 2017

1 reference

Europe PubMed Central

15 August 2017

1 reference

Europe PubMed Central

15 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q31050092&oldid=1946887382"